Clinical Trial Update: Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial of Botulinum toxin type A for neuropathic pain in diabetic polyneuropathy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy
• Neuropathic Pain

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Catholic University of Korea Saint Paul's Hospital | Conditions: Neuralgia | EARLY_Phase 1 | Status: TERMINATED